221 related articles for article (PubMed ID: 24692520)
1. Plasma fibrinogen along with patient-reported outcome measures enhances management of polymyalgia rheumatica: a prospective study.
McCarthy EM; MacMullan PA; Al-Mudhaffer S; Madigan A; Donnelly S; McCarthy CJ; Molloy ES; Kenny D; McCarthy GM
J Rheumatol; 2014 May; 41(5):931-7. PubMed ID: 24692520
[TBL] [Abstract][Full Text] [Related]
2. Plasma fibrinogen is an accurate marker of disease activity in patients with polymyalgia rheumatica.
McCarthy EM; MacMullan PA; Al-Mudhaffer S; Madigan A; Donnelly S; McCarthy CJ; Molloy ES; Kenny D; McCarthy GM
Rheumatology (Oxford); 2013 Mar; 52(3):465-71. PubMed ID: 23125391
[TBL] [Abstract][Full Text] [Related]
3. Erythrocyte sedimentation rate and C-reactive protein in the evaluation of disease activity and severity in polymyalgia rheumatica: a prospective follow-up study.
Cantini F; Salvarani C; Olivieri I; Macchioni L; Ranzi A; Niccoli L; Padula A; Boiardi L
Semin Arthritis Rheum; 2000 Aug; 30(1):17-24. PubMed ID: 10966209
[TBL] [Abstract][Full Text] [Related]
4. Patient-reported outcomes in polymyalgia rheumatica.
Matteson EL; Maradit-Kremers H; Cimmino MA; Schmidt WA; Schirmer M; Salvarani C; Bachta A; Dejaco C; Duftner C; Slott Jensen H; Poór G; Kaposi NP; Mandl P; Balint PV; Schmidt Z; Iagnocco A; Cantini F; Nannini C; Macchioni P; Pipitone N; Del Amo M; Espígol-Frigolé G; Cid MC; Martínez-Taboada VM; Nordborg E; Direskeneli H; Aydin SZ; Ahmed K; Hazelman B; Pease C; Wakefield RJ; Luqmani R; Abril A; Marcus R; Gonter NJ; Maz M; Crowson CS; Dasgupta B
J Rheumatol; 2012 Apr; 39(4):795-803. PubMed ID: 22422492
[TBL] [Abstract][Full Text] [Related]
5. EULAR response criteria for polymyalgia rheumatica: results of an initiative of the European Collaborating Polymyalgia Rheumatica Group (subcommittee of ESCISIT).
Leeb BF; Bird HA; Nesher G; Andel I; Hueber W; Logar D; Montecucco CM; Rovensky J; Sautner J; Sonnenblick M
Ann Rheum Dis; 2003 Dec; 62(12):1189-94. PubMed ID: 14644857
[TBL] [Abstract][Full Text] [Related]
6. The polymyalgia rheumatica activity score in daily use: proposal for a definition of remission.
Leeb BF; Rintelen B; Sautner J; Fassl C; Bird HA
Arthritis Rheum; 2007 Jun; 57(5):810-5. PubMed ID: 17530664
[TBL] [Abstract][Full Text] [Related]
7. A disease activity score for polymyalgia rheumatica.
Leeb BF; Bird HA
Ann Rheum Dis; 2004 Oct; 63(10):1279-83. PubMed ID: 15361387
[TBL] [Abstract][Full Text] [Related]
8. A study of the health assessment questionnaire to evaluate functional status in polymyalgia rheumatica.
Kalke S; Mukerjee D; Dasgupta B
Rheumatology (Oxford); 2000 Aug; 39(8):883-5. PubMed ID: 10952744
[TBL] [Abstract][Full Text] [Related]
9. Soluble interleukin 2 receptors in polymyalgia rheumatica/giant cell arteritis. Clinical and laboratory correlations.
Salvarani C; Macchioni P; Boiardi L; Rossi F; Casadei Maldini M; Mancini R; Beltrandi E; Spacca C; Lodi L; Portioli I
J Rheumatol; 1992 Jul; 19(7):1100-6. PubMed ID: 1512765
[TBL] [Abstract][Full Text] [Related]
10. Contribution of the polymyalgia rheumatica activity score to glucocorticoid dosage adjustment in everyday practice.
Cleuziou C; Binard A; De Bandt M; Berthelot JM; Saraux A
J Rheumatol; 2012 Feb; 39(2):310-3. PubMed ID: 22174199
[TBL] [Abstract][Full Text] [Related]
11. Circulating CD8+ T cells in polymyalgia rheumatica and giant cell arteritis: a review.
Martinez-Taboada VM; Blanco R; Fito C; Pacheco MJ; Delgado-Rodriguez M; Rodriguez-Valverde V
Semin Arthritis Rheum; 2001 Feb; 30(4):257-71. PubMed ID: 11182026
[TBL] [Abstract][Full Text] [Related]
12. Serum markers associated with disease activity in giant cell arteritis and polymyalgia rheumatica.
van der Geest KS; Abdulahad WH; Rutgers A; Horst G; Bijzet J; Arends S; Roffel MP; Boots AM; Brouwer E
Rheumatology (Oxford); 2015 Aug; 54(8):1397-402. PubMed ID: 25724206
[TBL] [Abstract][Full Text] [Related]
13. Acute-phase reactants and the risk of relapse/recurrence in polymyalgia rheumatica: a prospective followup study.
Salvarani C; Cantini F; Niccoli L; Macchioni P; Consonni D; Bajocchi G; Vinceti M; Catanoso MG; Pulsatelli L; Meliconi R; Boiardi L
Arthritis Rheum; 2005 Feb; 53(1):33-8. PubMed ID: 15696567
[TBL] [Abstract][Full Text] [Related]
14. Polymyalgia rheumatica with low erythrocyte sedimentation rate at diagnosis.
Proven A; Gabriel SE; O'Fallon WM; Hunder GG
J Rheumatol; 1999 Jun; 26(6):1333-7. PubMed ID: 10381052
[TBL] [Abstract][Full Text] [Related]
15. Value of (18)F-FDG PET/CT for therapeutic assessment of patients with polymyalgia rheumatica receiving tocilizumab as first-line treatment.
Palard-Novello X; Querellou S; Gouillou M; Saraux A; Marhadour T; Garrigues F; Abgral R; Salaün PY; Devauchelle-Pensec V
Eur J Nucl Med Mol Imaging; 2016 Apr; 43(4):773-9. PubMed ID: 26753600
[TBL] [Abstract][Full Text] [Related]
16. Adrenal gland hypofunction in active polymyalgia rheumatica. effect of glucocorticoid treatment on adrenal hormones and interleukin 6.
Cutolo M; Straub RH; Foppiani L; Prete C; Pulsatelli L; Sulli A; Boiardi L; Macchioni P; Giusti M; Pizzorni C; Seriolo B; Salvarani C
J Rheumatol; 2002 Apr; 29(4):748-56. PubMed ID: 11950017
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcomes, quality of life, and diagnostic uncertainty in the first year of polymyalgia rheumatica.
Hutchings A; Hollywood J; Lamping DL; Pease CT; Chakravarty K; Silverman B; Choy EH; Scott DG; Hazleman BL; Bourke B; Gendi N; Dasgupta B
Arthritis Rheum; 2007 Jun; 57(5):803-9. PubMed ID: 17530680
[TBL] [Abstract][Full Text] [Related]
18. Performance of the polymyalgia rheumatica activity score for diagnosing disease flares.
Binard A; de Bandt M; Berthelot JM; Saraux A;
Arthritis Rheum; 2008 Feb; 59(2):263-9. PubMed ID: 18240260
[TBL] [Abstract][Full Text] [Related]
19. Imbalance between endothelial injury and repair in patients with polymyalgia rheumatica: improvement with corticosteroid treatment.
Pirro M; Bocci EB; Di Filippo F; Schillaci G; Mannarino MR; Bagaglia F; Gerli R; Mannarino E
J Intern Med; 2012 Aug; 272(2):177-84. PubMed ID: 22211720
[TBL] [Abstract][Full Text] [Related]
20. Concordance and agreement between different activity scores in polymyalgia rheumatica.
D'Agostino J; Souki A; Lohse A; Carvajal Alegria G; Dernis E; Richez C; Truchetet ME; Wendling D; Toussirot E; Perdriger A; Gottenberg JE; Felten R; Fautrel B; Chiche L; Hilliquin P; Le Henaff C; Dervieux B; Direz G; Chary-Valckenaere I; Cornec D; Guellec D; Marhadour T; Nowak E; Saraux A; Devauchelle-Pensec V
RMD Open; 2024 Mar; 10(1):. PubMed ID: 38490696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
